Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106496146A reveals a sulfonic acid ionic liquid catalyzed method for high-yield quinazolinone synthesis, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN105541734B reveals efficient quinazolinone synthesis. Low temperature copper catalysis offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced one-pot synthesis of quinazolinone derivatives using aqueous copper catalysis. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN105732521A reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel one-step nickel catalysis replaces toxic cyanogen bromide. High yield, mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN104710368A details a high-yield Pd-catalyzed route for 2-benzoyl quinazolinone. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114736206B reveals metal-free aqueous synthesis for quinazolinones. Achieve cost reduction and supply chain reliability with green radical cyclization technology.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Advanced catalytic synthesis of 4-(3H)-quinazolinone derivatives via patent CN114230526B. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediates supply chain solutions.
Patent CN112608281A reveals a room-temperature synthesis of quinazolinones with high purity, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN118515620A details a heterogeneous Pd/ACFs catalytic method for high-purity quinazolinone synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101351459A reveals a novel acetic acid-catalyzed route for 4(3H)-quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN116159594A introduces a metal-free photocatalytic route for quinazolinones. This green method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel aqueous palladium-catalyzed route offers high yields up to 94% and simplified purification for complex heterocyclic pharmaceutical intermediates.
Novel one-step quinazolinone preparation method ensures high yield and purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction and scalable production capabilities.
Novel palladium-catalyzed quinazolinone synthesis offers high yield and scalable production capabilities for global pharmaceutical intermediates manufacturing supply chains.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108558778B details a green one-pot synthesis of dihydroquinazolinones using o-nitrobenzonitrile, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.